We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Potential Therapeutic Strategies for Lung and Breast Cancers through Understanding the Anti-Angiogenesis Resistance Mechanisms.
- Authors
Ramadan, Wafaa S.; Zaher, Dana M.; Altaie, Alaa M.; Talaat, Iman M.; Elmoselhi, Adel
- Abstract
Breast and lung cancers are among the top cancer types in terms of incidence and mortality burden worldwide. One of the challenges in the treatment of breast and lung cancers is their resistance to administered drugs, as observed with angiogenesis inhibitors. Based on clinical and pre-clinical findings, these two types of cancers have gained the ability to resist angiogenesis inhibitors through several mechanisms that rely on cellular and extracellular factors. This resistance is mediated through angiogenesis-independent vascularization, and it is related to cancer cells and their microenvironment. The mechanisms that cancer cells utilize include metabolic symbiosis and invasion, and they also take advantage of neighboring cells like macrophages, endothelial cells, myeloid and adipose cells. Overcoming resistance is of great interest, and researchers are investigating possible strategies to enhance sensitivity towards angiogenesis inhibitors. These strategies involved targeting multiple players in angiogenesis, epigenetics, hypoxia, cellular metabolism and the immune system. This review aims to discuss the mechanisms of resistance to angiogenesis inhibitors and to highlight recently developed approaches to overcome this resistance.
- Subjects
LUNG cancer; BREAST cancer; NEOVASCULARIZATION inhibitors; NEOVASCULARIZATION; FAT cells; CANCER cells
- Publication
International Journal of Molecular Sciences, 2020, Vol 21, Issue 2, p1
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms21020565